Signaturefd, LLC Atara Biotherapeutics, Inc. Transaction History

Signaturefd, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$1.5 - $3.04 $447 - $905	-298 Reduced 11.05%	2,400 $3,000
Q1 2023 Apr 28, 2023	SELL	$2.8 - $5.46 $2,128 - $4,149	-760 Reduced 21.98%	2,698 $7,000
Q4 2022 Jan 27, 2023	SELL	$2.85 - $5.18 $6,954 - $12,639	-2,440 Reduced 41.37%	3,458 $11,000
Q3 2022 Nov 08, 2022	BUY	$2.85 - $8.73 $7,891 - $24,173	2,769 Added 88.49%	5,898 $22,000
Q2 2022 Aug 10, 2022	BUY	$4.69 - $9.84 $2,466 - $5,175	526 Added 20.21%	3,129 $24,000
Q1 2022 May 02, 2022	BUY	$8.44 - $16.89 $1,713 - $3,428	203 Added 8.46%	2,603 $24,000
Q1 2021 Apr 30, 2021	BUY	$14.0 - $20.72 $33,110 - $49,002	2,365 Added 6757.14%	2,400 $34,000
Q4 2020 Feb 11, 2021	BUY	$12.67 - $26.23 $443 - $918	35 New	35 $1,000
Q2 2020 Jul 30, 2020	SELL	$7.53 - $14.93 $2,567 - $5,091	-341 Closed	0 $0
Q1 2020 Apr 23, 2020	BUY	$5.69 - $17.78 $1,940 - $6,062	341 New	341 $3,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $949M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.